Pierre Bourdage

May 26-27, 2021 | Virtual Conference

Register Today

Pierre Bourdage

Global Head, Biopharmaceuticals
Sandoz

In his role as Sandoz Global Head, Biopharmaceuticals, Pierre Bourdage leads the organization that is responsible for the strategy and commercialization of biopharmaceuticals and represents the Biopharmaceuticals unit as member of the Sandoz Executive Committee. Sandoz has eight biosimilars approved in total, has launched three biosimilars in 2018 and continues to invest and expand a leading biosimilar pipeline.

Pierre brings considerable experience in launch excellence and team leadership as well as brand and franchise management with over 16 years in the pharmaceutical and healthcare industry. He enjoys leading collaborative and externally oriented teams, and is passionate about the Biopharmaceuticals business unit purpose in helping patients and healthcare systems improve access and affordability to biologic medicines.

Prior to joining Sandoz Pierre worked within Novartis owned companies Alcon and Novartis Pharmaceuticals where he held numerous country and global roles over a 16-year period.  This career path has allowed Pierre to build experience in innovative pharmaceuticals, medical devices and generics.  He has deep therapeutic area experience spanning immunology, ophthalmology, cardiology, dermatology and neuroscience

Thank You For Joining Us

Dividing Lines

If you couldn't make it to the Access! 2021 virtual conference, contact Aquera Agee at aquera.agee@accessiblemeds.org for the on-demand access.

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

Access 2021 will use the information you provide on this form to be in touch with you and to provide updates and marketing.
Skip to content